ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,879Medicare Part D Prescriptions Filled, Including Refills

Rank: 235 out of 2456

$450K Total Retail Price of All Prescriptions

Rank: 283 out of 2456

322 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 322 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 322 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 8,229 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 406 406 1 9
SIMVASTATIN 332 308 2 2
LEVOTHYROXINE SODIUM 327 313 3 4
AMLODIPINE BESYLATE 306 257 4 5
FUROSEMIDE 300 298 5 8
OMEPRAZOLE 294 276 6 3
MIRTAZAPINE 275 275 7 29
TRAZODONE HCL 235 233 8 17
LISINOPRIL 233 218 9 1
ATORVASTATIN CALCIUM 223 201 10 12
DONEPEZIL HCL 194 194 11 23
PRAVASTATIN SODIUM 187 156 12 15
METOPROLOL TARTRATE 186 172 13 10
ATENOLOL 151 148 14 6
CITALOPRAM HBR 132 129 15 14
LOSARTAN POTASSIUM 129 129 16 18
BENICAR 124 119 17 160
GABAPENTIN 123 112 18 16
METFORMIN HCL 104 93 19 11
DIVALPROEX SODIUM 100 90 20 51
NAMENDA 99 99 21 42
METOPROLOL SUCCINATE 99 98 21 13
SERTRALINE HCL 98 91 23 21
PREDNISONE 97 94 24 39
PANTOPRAZOLE SODIUM 96 91 25 37
QUETIAPINE FUMARATE 88 88 26 47
HYDROCHLOROTHIAZIDE 76 51 27 7
PAROXETINE HCL 71 65 28 56
ALENDRONATE SODIUM 70 66 29 19
METFORMIN HCL ER 61 44 30 59
FLUOXETINE HCL 58 30 31 45
POTASSIUM CHLORIDE 52 49 32 33
ALLOPURINOL 52 52 32 27
CLOPIDOGREL 51 49 34 55
CARBIDOPA-LEVODOPA 50 50 35 82
RISPERIDONE 50 50 35 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.